William Paul Skelton

Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study

Rohit Bishnoi, Young‐Rock Hong, Chintan Shah et al. · Cancer Medicine · 2019 · 64 citations · Full text

Medicine, Oncology, Pharmacology +9

Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients

Rohit Bishnoi, Ravneet Bajwa, Aaron J Franke et al. · Experimental Hematology and Oncology · 2017 · 59 citations · Full text

Medicine, Hematology, Immunology +16

Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer

Chintan Shah, Young‐Rock Hong, Rohit Bishnoi et al. · Frontiers in Oncology · 2020 · 44 citations · Full text

Medicine, Oncology, Pharmacology +13

Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab

Jad Chahoud, William Paul Skelton, Philippe E. Spiess et al. · Frontiers in Oncology · 2020 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17

A multi‑center retrospective analysis of the effect of DPP4 inhibitors on progression‑free survival in advanced airway and colorectal cancers

Azka Ali, Alejandra Fuentes, William Paul Skelton et al. · Molecular and Clinical Oncology · 2018 · 38 citations · Full text

Medicine, Oncology, Pharmacology +11